Equibles does not estimate personal net worth.
Get an email with a short summary when Tarsus Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get TARS alertsElizabeth Yeu is recorded as Chairman at Staar Surgical Co (STAA) since February 26, 2025. Staar Surgical Co reported in an 8-K filed February 26, 2025 that Elizabeth Yeu was appointed Board Chair, effective February 26, 2025. Elizabeth Yeu has spoken on 2 earnings calls across 1 company, most recently for Tarsus Pharmaceuticals, Inc. on November 3, 2026. Tarsus Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Staar Surgical Co is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Tarsus Pharmaceuticals, Inc. includes Bobak Azamian (CEO and Chairman), Jeffrey S. Farrow (CFO), Leonard Greenstein (CFO) and 7 others.
“Elizabeth Yeu, M.D., who has served as a member of the Board since 2021, has been elected by the Board to serve as Board Chair.”
“Hi, this is Liz Yu, and with regards to your guilty retinal question, as you know, it's a once-daily oral therapy, and that mechanism is designed to support that normal visual cycle, and what our retina KOLs are telling us is that this is a really unique and interesting mechanism that they are keenly looking forward…”
“When we think about the patients that we're taking care of, certainly I'm taking a view of it from the patient perspective. And while most of the diseases that we as eye care providers see, they worsen with aging.”
2025-02-26–present
Source not stated
Start not stated–2026-01-14
Biotechnology · Healthcare
STAA
Medical Instruments & Supplies · Healthcare
Chairman
2025-02-26–present
